Gwt-tud Gmbh

This large, international Phase 3 study is testing whether adding a newer drug called polatuzumab vedotin to a standard chemotherapy combination (R-ICE) works better for controlling aggressive lymphoma that has come back or didn't respond to first treatment. About 306 adults with…

This study is testing a drug called luspatercept to see if it can help patients with a specific type of lower-risk myelodysplastic syndrome (MDS) who have anemia and require regular blood transfusions. The main goal is to see if the treatment can allow patients to go at least 8 w…